ABVX Abivax SA

DGAP-News: Abivax secures EUR 15m non-dilutive financing from Kreos Capital

DGAP-News: Abivax secures EUR 15m non-dilutive financing from Kreos Capital
EN
13/10/2020

Underlying

ABVXAbivax SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Abivax SA

 PRESS RELEASE
Free
ABVX ABIVAX SA

Abivax Announces Results of its June 6, 2025 Annual General Meeting

Abivax Announces Results of its June 6, 2025 Annual General Meeting Abivax Announces Results of its June 6, 2025 Annual General Meeting PARIS, France, June 11, 2025, 10:00 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the inflammatory response in patients with chronic inflammatory diseases, held its annual general meeting of shareholders on June 6, 2025 (the “General Meeting”), which was chaire...

June 11, 2025 1 EN
Oliver Metzger ... (+2)
  • Oliver Metzger
  • Thomas Zlowodzki
OSE OSE IMMUNOTHERAPEUTICS SA
GXI GERRESHEIMER AG
ABVX ABIVAX SA
INEA FONCIERE INEA
EKI EKINOPS SA
NEX NEXANS SA
BIG BIGBEN INTERACTIVE SA
MEDCL MEDINCELL SA
WAVE WAVESTONE SA
NACON NACON SASU
TE TECHNIP ENERGIES NV
NVM NOVEM GROUP SA
06/03/25 June 3, 2025 1 EN
Oliver Metzger ... (+2)
  • Oliver Metzger
  • Thomas Zlowodzki
OSE OSE IMMUNOTHERAPEUTICS SA
GXI GERRESHEIMER AG
ABVX ABIVAX SA
INEA FONCIERE INEA
EKI EKINOPS SA
NEX NEXANS SA
BIG BIGBEN INTERACTIVE SA
MEDCL MEDINCELL SA
WAVE WAVESTONE SA
NACON NACON SASU
TE TECHNIP ENERGIES NV
NVM NOVEM GROUP SA
06/03/25 June 3, 2025 1 FR
Damien Choplain ... (+2)
  • Damien Choplain
  • Martial Descoutures
06/03/25 June 3, 2025 1 EN
Damien Choplain ... (+2)
  • Damien Choplain
  • Martial Descoutures
06/03/25 June 3, 2025 1 FR

ResearchPool Subscriptions

Get the most out of your insights

Get in touch